Over the past five years or so, there probably was no company that better represented the promise of mid-sized biotech companies than Onyx Pharmaceuticals. So when Onyx was sold in fall 2013 to Amgen Inc., there was a collective holding of breath about the future of the 800-employee company’s future in South San Francisco, and what it meant for CEO Tony Coles.
Hey, check out all the research scientist jobs. Post your resume today!
